Home > National Drug Code (NDC) > Moexipril Hydrochloride and Hydrochlorothiazide

Moexipril Hydrochloride and Hydrochlorothiazide - 0574-0133-01 - (Moexipril Hydrochloride and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Moexipril Hydrochloride and Hydrochlorothiazide

Product NDC: 0574-0133
Proprietary Name: Moexipril Hydrochloride and Hydrochlorothiazide
Non Proprietary Name: Moexipril Hydrochloride and Hydrochlorothiazide
Active Ingredient(s): 12.5; 7.5    mg/1; mg/1 & nbsp;   Moexipril Hydrochloride and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET, COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Moexipril Hydrochloride and Hydrochlorothiazide

Product NDC: 0574-0133
Labeler Name: Paddock Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA090096
Marketing Category: ANDA
Start Marketing Date: 20090701

Package Information of Moexipril Hydrochloride and Hydrochlorothiazide

Package NDC: 0574-0133-01
Package Description: 100 TABLET, COATED in 1 BOTTLE (0574-0133-01)

NDC Information of Moexipril Hydrochloride and Hydrochlorothiazide

NDC Code 0574-0133-01
Proprietary Name Moexipril Hydrochloride and Hydrochlorothiazide
Package Description 100 TABLET, COATED in 1 BOTTLE (0574-0133-01)
Product NDC 0574-0133
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Moexipril Hydrochloride and Hydrochlorothiazide
Dosage Form Name TABLET, COATED
Route Name ORAL
Start Marketing Date 20090701
Marketing Category Name ANDA
Labeler Name Paddock Laboratories, Inc.
Substance Name HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Strength Number 12.5; 7.5
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Moexipril Hydrochloride and Hydrochlorothiazide


General Information